Vanguard Group’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-85,508
| Closed | -$11.5M | – | 4562 |
|
|
2022
Q3 | $11.5M | Buy |
85,508
+998
| +1% | +$171K | ﹤0.01% | 2882 |
|
|
2022
Q2 | $13.7M | Buy |
84,510
+765
| +0.9% | +$119K | ﹤0.01% | 2826 |
|
|
2022
Q1 | $15.8M | Buy |
83,745
+4,245
| +5% | +$902K | ﹤0.01% | 2908 |
|
|
2021
Q4 | $21.5M | Sell |
79,500
-5,861
| -7% | -$1.98M | ﹤0.01% | 2804 |
|
|
2021
Q3 | $31M | Buy |
85,361
+714
| +0.8% | +$233K | ﹤0.01% | 2626 |
|
|
2021
Q2 | $29.1M | Sell |
84,647
-15,470
| -15% | -$5.12M | ﹤0.01% | 2644 |
|
|
2021
Q1 | $34.8M | Sell |
100,117
-123
| -0.1% | -$40.7K | ﹤0.01% | 2502 |
|
|
2020
Q4 | $25.9M | Sell |
100,240
-23,403
| -19% | -$6.44M | ﹤0.01% | 2513 |
|
|
2020
Q3 | $35.4M | Buy |
123,643
+993
| +0.8% | +$233K | ﹤0.01% | 2188 |
|
|
2020
Q2 | $23.1M | Sell |
122,650
-121,043
| -50% | -$19.7M | ﹤0.01% | 2354 |
|
|
2020
Q1 | $30M | Sell |
243,693
-1,018,860
| -81% | -$159M | ﹤0.01% | 2101 |
|
|
2019
Q4 | $209M | Buy |
1,262,553
+5,420
| +0.4% | +$901K | 0.01% | 1360 |
|
|
2019
Q3 | $154M | Buy |
1,257,133
+14,881
| +1% | +$1.98M | 0.01% | 1494 |
|
|
2019
Q2 | $154M | Buy |
1,242,252
+1,712
| +0.1% | +$217K | 0.01% | 1518 |
|
|
2019
Q1 | $164M | Buy |
1,240,540
+43,244
| +4% | +$5.83M | 0.01% | 1458 |
|
|
2018
Q4 | $168M | Buy |
1,197,296
+133,060
| +13% | +$17.6M | 0.01% | 1346 |
|
|
2018
Q3 | $183M | Buy |
1,064,236
+105,702
| +11% | +$17.8M | 0.01% | 1450 |
|
|
2018
Q2 | $147M | Sell |
958,534
-33,886
| -3% | -$6.04M | 0.01% | 1554 |
|
|
2018
Q1 | $167M | Buy |
992,420
+633,591
| +177% | +$85.8M | 0.01% | 1419 |
|
|
2017
Q4 | $35.1M | Buy |
358,829
+247,947
| +224% | +$22.7M | ﹤0.01% | 2245 |
|
|
2017
Q3 | $11.5M | Buy |
+110,882
| New | +$8.26M | ﹤0.01% | 2743 |
|
Other funds holding ONC
BBA
HA
CII
